The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Novel reduced-dose intranasal oxytocin followed by a period of positive social interaction improved symptoms in young children with autism spectrum disorder (ASD). In the study, improvement was seen in objective and subjective measures, … Read more
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The burden of self-reported post-acute symptoms and possible sequelae, particularly fatigue and neurocognitive impairment, remains significant 6 to 12 months after acute, even among young and middle-aged adults after mild acute SARS-CoV-2 infection, … Read more
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Both placebo and nocebo effects can greatly affect the interpretation of outcomes in randomized controlled trials of chronic neuropathic pain treatments. When trials are being designed and interpreted, these effects need to be … Read more
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaway Cerebrospinal fluid (CSF) inflammatory marker levels were found to be associated with changes in gray matter volume and cortical thickness in the frontal, orbitofrontal, and temporal regions in hospitalized patients with severe SARS-CoV-2 … Read more
The study covered in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Patients with COVID-19 are at increased risk for peripheral nerve injuries (PNIs) that can lead to long-term neurologic impairment. Mechanical stress may contribute to the development of PNIs. The most commonly observed site … Read more